The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -3.79% | -2.96% | -0.34% | 19.97% | 24.85% | 21.47% |
| Ipca Labs. | -0.83% | -3.75% | 6.93% | 14.65% | 21.25% | 18.82% |
| Anthem Bioscienc | -1.29% | -2.74% | -0.66% | -0.03% | 30.04% | 1.91% |
| Glaxosmi. Pharma | 0.70% | 1.11% | 6.74% | 2.79% | 7.45% | -18.63% |
| Gland Pharma | -0.33% | -3.30% | 0.27% | 34.12% | 41.96% | 15.93% |
| Emcure Pharma | 0.59% | 1.13% | 1.81% | 14.99% | 26.74% | 34.19% |
| Wockhardt | 0.21% | -3.78% | -5.09% | 28.39% | 37.21% | 9.78% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah